Cover |
Apr. 22, 2026 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Amendment No. 1 on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K filed by Indaptus Therapeutics Inc. with the U.S. Securities and Exchange Commission on April 23, 2026 (the “Original Report”). This Amendment is being filed solely to reflect that, subsequent to the filing of the Original Report, the Company was informed by the director identified in the Original Report as Yí Zhang (Johnny) that he had changed his legal name to Johnny Fox Arrowsmith. Dr. Arrowsmith uses “Yi Zhang” as his professional name. The disclosure in the Original Report has been updated accordingly to reflect the director’s current legal name. Except as expressly set forth herein, this Amendment does not modify or update any other disclosures contained in the Original Report, and this Amendment should be read in conjunction with the Original Report. The Original Report otherwise continues to speak as of the date originally filed. |
| Document Period End Date | Apr. 22, 2026 |
| Entity File Number | 001-40652 |
| Entity Registrant Name | INDAPTUS THERAPEUTICS, INC. |
| Entity Central Index Key | 0001857044 |
| Entity Tax Identification Number | 86-3158720 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 3 Columbus Circle 15th Floor |
| Entity Address, City or Town | New York |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 10019 |
| City Area Code | (646) |
| Local Phone Number | 427-2727 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.01 par value |
| Trading Symbol | INDP |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |